WUXI BIOLOGICS (Germany) Top Insiders

1FW1 Stock  EUR 3.38  0.14  3.98%   
Examination of WUXI BIOLOGICS's management performance can provide insight into the company performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in WUXI BIOLOGICS UNSPADR2. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Symbol  1FW1
Name  WUXI BIOLOGICS UNSPADR2
TypeStock
Country  
 Germany
Exchange  F

Information on WUXI BIOLOGICS UNSPADR2 Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

WUXI BIOLOGICS Management Team Effectiveness

The company has return on total asset (ROA) of 0.0551 % which means that it generated a profit of $0.0551 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.123 %, meaning that it generated $0.123 on every $100 dollars invested by stockholders. WUXI BIOLOGICS's management efficiency ratios could be used to measure how well WUXI BIOLOGICS manages its routine affairs as well as how well it operates its assets and liabilities.

WUXI BIOLOGICS Workforce Comparison

WUXI BIOLOGICS UNSPADR2 is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 60,453. WUXI BIOLOGICS retains roughly 10,593 in number of employees claiming about 18% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.31 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.31.

WUXI BIOLOGICS UNSPADR2 Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. WUXI BIOLOGICS UNSPADR2 Price Series Summation is a cross summation of WUXI BIOLOGICS price series and its benchmark/peer.

About WUXI BIOLOGICS Management Performance

The success or failure of an entity such as WUXI BIOLOGICS UNSPADR2 often depends on how effective the management is. WUXI BIOLOGICS management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of WUXI management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the WUXI management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
WuXi Biologics Inc., an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the Peoples Republic of China, North America, Europe, and internationally. WuXi Biologics Inc. is a subsidiary of WuXi Biologics Holdings Limited. WUXI BIOLOGICS is traded on Frankfurt Stock Exchange in Germany.

Complementary Tools for WUXI Stock analysis

When running WUXI BIOLOGICS's price analysis, check to measure WUXI BIOLOGICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WUXI BIOLOGICS is operating at the current time. Most of WUXI BIOLOGICS's value examination focuses on studying past and present price action to predict the probability of WUXI BIOLOGICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WUXI BIOLOGICS's price. Additionally, you may evaluate how the addition of WUXI BIOLOGICS to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities